Tenaya therapeutics to participate at the td cowen genetic medicines & rna summit

South san francisco, calif., june 18, 2024 (globe newswire) -- tenaya therapeutics, inc. (nasdaq: tnya), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies that address the underlying causes of heart disease, today announced that faraz ali, chief executive officer, will participate in the td cowen genetic medicines & rna summit on friday, june 21, 2024, at 11:20 am et.
COWN Ratings Summary
COWN Quant Ranking